Welcome to YLOAN.COM
yloan.com » Marketing » Oncology Market Forecast To 2015: Brand Spending And Development Opportunities
Marketing Advertising Branding Careers-Employment Change-Management Customer Service Entrepreneurialism Ethics Marketing-Direct Negotiation Outsourcing PR Presentation Resumes-Cover-Letters Sales Sales-Management Sales-Teleselling Sales-Training Strategic-Planning Team-Building Top7-or-Top10-Tips Workplace-Communication aarkstore corporate advantages development collection global purchasing rapidshare grinding wildfire shipping trading economy wholesale agency florida attorney strategy county consumer bills niche elliptical

Oncology Market Forecast To 2015: Brand Spending And Development Opportunities

Chart the future of the global oncology market


Explore the fiercely competitive oncology market with the most comprehensive resource available. Augment or build your models with deep, meticulously researched data - and expand your understanding of different drugs, classes and sub-classes.

Equip your team with 119 brand profiles, all of which contain painstaking detail

Historical and projected sales from 2006-2015


Current and projected approvals

Critical clinical trials to watch

Analysis that places each drug in context against key competitors and market events

Patent, generics and litigation information

After scouring the profiles, gauge your resource levels: Brand spending data tracks real-world dollars for promotion, medical affairs, market access and more - information you won't find anywhere else.

Give your teams all the oncology market research they need to make critical product decisions!

Table of Contents :

Products Profiled in Report

Alkylating Agents

Eloxatin (oxaliplatin) (Sanofi-Aventis)

Picoplatin (Poniard)

Temodar (temozolomide) (Merck)

Treanda (bendamustine) (Cephalon)

Antimetabolites

Alimta (pemetrexed) (Eli Lilly)

Clolar/Evoltra (clofarabine) (Genzyme, Bioenvision)

Dacogen (Eisai, Johnson & Johnson)

Fludara (fludarabine phosphate) (Genzyme)

Folotyn (PDX) (Allos Therapeutics)

Gemzar (gemcitabine hydrochloride) (Eli Lilly)

Vidaza (azacitine) (Celgene)

Xeloda (capecitabine) (Roche)

For more information please contact :

http://www.aarkstore.com/reports/Oncology-Market-Forecast-to-2015-Brand-Spending-and-Development-Opportunities-42766.html

http://blogs.aarkstore.com/

From:Aarkstore Enterprise

Contact: Neel

Email: press@aarkstore.com

URL: www.aarkstore.com

by: Aarkstore
Chatuchak Weekend Market- An Experience! The Worldwide Market For Cancer Diagnostics, 4th Edition --- Aarkstore Enterprise Poverty to Profit: Islamic Microfinance - Part 1 Ben Thanh Market, A Feast For The Eyes Sell your products worldwide using online marketing Sumitomo Mitsui Banking Corporation - Swot Analysis - Market Research Report On Aarkstore Enterprise The Market For Prescription Dermatological Drugs, 7th Edition --- Aarkstore Enterprise Diabetes Market Forecast To 2015- Aarkstore Enterprise Casual and upmarket dsquared2 tees onsale The World Anesthesia Drug Market --- Aarkstore Enterprise The Reputation Of Article Marketing Services Global Market For Medical Devices --- Aarkstore Enterprise Making Money With Your website: How To Monetize For Long Term Profits
print
www.yloan.com guest:  register | login | search IP(216.73.216.144) California / Anaheim Processed in 0.017691 second(s), 7 queries , Gzip enabled , discuz 5.5 through PHP 8.3.9 , debug code: 66 , 2035, 66,
Oncology Market Forecast To 2015: Brand Spending And Development Opportunities Anaheim